【レポートの概要（一部）】
Table of Content
Chapter 1.Methodology And Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Therapeutic drug monitoring market – Industry Snapshot and Key Buying Criteria, 2013 – 2024
Chapter 3. Therapeutic Drug Monitoring Market, Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects
3.3. Therapeutic drug monitoring market: Market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry Analysis – Porter’s
3.6. Therapeutic drug monitoring market PESTEL analysis, 2015
Chapter 4. Therapeutic Drug Monitoring Market, Product Outlook
4.1. Therapeutic drug monitoring market share by product, 2015 & 2024
4.2. Consumables
4.2.1. Consumables market estimates and forecasts, 2013 – 2024 (USD Million)
4.3. Equipment
4.3.1. Equipment market estimates and forecasts, 2013 – 2024 (USD Million)
4.4. Others
4.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 5. Therapeutic Drug Monitoring Market, Technology Outlook
5.1. Therapeutic drug monitoring market share by technology, 2015 & 2024
5.2. Immunoassays
5.2.1. Immunoassays market estimates and forecasts, 2013 – 2024 (USD Million)
5.3. Proteomic technologies
5.3.1. Proteomic technologies market estimates and forecasts, 2013 – 2024 (USD Million)
5.4. Others
5.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6. Therapeutic Drug Monitoring Market, Drug Class Outlook
6.1. Therapeutic drug monitoring market share by drug class, 2015 & 2024
6.2. Anti – epileptics
6.2.1. Anti – epileptic market estimates and forecasts, 2013 – 2024 (USD Million)
6.3. Antibiotics
6.3.1. Antibiotics market estimates and forecasts, 2013 – 2024 (USD Million)
6.4. Immunosuppressants
6.4.1. Immunosuppressants market estimates and forecasts, 2013 – 2024 (USD Million)
6.5. Psychoactive drugs
6.5.1. Psychoactive drugs market estimates and forecasts, 2013 – 2024 (USD Million)
6.6. Anti-arrhythmic drugs
6.6.1. Anti-arrhythmic drugs market estimates and forecasts, 2013 – 2024 (USD Million)
6.7. Others
6.7.1. Others drug market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7. Therapeutic Drug Monitoring Market, End – use Outlook
7.1. Therapeutic drug monitoring market share by end – use, 2015 & 2024
7.2. Hospital labs
7.2.1. Hospital labs market estimates and forecasts, 2013 – 2024 (USD Million)
7.3. Private labs
7.3.1. Private labs market estimates and forecasts, 2013 – 2024 (USD Million)
7.4. Others
7.4.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 8. Drug Monitoring Market Regional Outlook
8.1. Therapeutic drug monitoring market share by region, 2015 & 2024
8.2. North America
8.2.1. North America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.2.1.1. U.S. market estimates and forecasts
8.2.1.2. Canada market estimates and forecasts
8.2.2. North America market estimates and forecasts, by technology type, 2013 – 2024 (USD Million)
8.2.2.1. U.S. market estimates and forecasts
8.2.2.2. Canada market estimates and forecasts
8.2.3. North America market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.2.3.1. U.S. market estimates and forecasts
8.2.3.2. Canada market estimates and forecasts
8.2.4. North America market estimates and forecasts, by end – use type, 2013 – 2024 (USD Million)
8.2.4.1. U.S. market estimates and forecasts
8.2.4.2. Canada market estimates and forecasts
8.3. Europe
8.3.1. Europe market estimates and forecasts, by product , 2013 – 2024 (USD Million)
8.3.1.1. UK market estimates and forecasts
8.3.1.2. Germany market estimates and forecasts
8.3.2. Europe market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.3.2.1. UK market estimates and forecasts
8.3.2.2. Germany market estimates and forecasts
8.3.3. Europe market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.3.3.1. UK market estimates and forecasts
8.3.3.2. Germany market estimates and forecasts
8.3.4. Europe market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.3.4.1. UK market estimates and forecasts
8.3.4.2. Germany market estimates and forecasts
8.4. Asia Pacific
8.4.1. Asia Pacific market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.4.1.1. Japan market estimates and forecasts
8.4.1.2. China market estimates and forecasts
8.4.2. Asia Pacific market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.4.2.1. Japan market estimates and forecasts
8.4.2.2. China market estimates and forecasts
8.4.3. Asia Pacific market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.4.3.1. Japan market estimates and forecasts
8.4.3.2. China market estimates and forecasts
8.4.4. Asia Pacific market estimates and forecasts, by end – use , 2013 – 2024 (USD Million)
8.4.4.1. Japan market estimates and forecasts
8.4.4.2. China market estimates and forecasts
8.5. Latin America
8.5.1. Latin America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
8.5.1.1. Brazil market estimates and forecasts
8.5.2. Latin America market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.5.2.1. Brazil market estimates and forecasts
8.5.3. Latin America market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.5.3.1. Brazil market estimates and forecasts
8.5.4. Latin America market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.5.4.1. Brazil market estimates and forecasts
8.6. MEA
8.6.1. MEA market estimates and forecasts, by product , 2013 – 2024 (USD Million)
8.6.1.1. South Africa market estimates and forecast
8.6.2. MEA market estimates and forecasts, by technology, 2013 – 2024 (USD Million)
8.6.2.1. South Africa market estimates and forecast
8.6.3. MEA market estimates and forecasts, by drug class, 2013 – 2024 (USD Million)
8.6.3.1. South Africa market estimates and forecast
8.6.4. MEA market estimates and forecasts, by end – use, 2013 – 2024 (USD Million)
8.6.4.1. South Africa market estimates and forecast
Chapter 9. Competitive Landscape
9.1. Roche Diagnostics
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. biomérieux, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Abbott Laboratories, Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Danaher Corporation
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Alere, Inc.
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. Agilent Technologies, Inc.
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Thermo Fisher Scientific, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Siemens Healthcare GmbH
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. Bio-Rad Laboratories, Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：治療薬の世界市場分析：製品別（消耗品、機器、データ管理サービス）、技術別（イムノアッセイ、プロテオーム技術）、薬品別（抗てんかん剤、抗生物質、免疫抑制剤、抗不整脈剤）、エンドユーザー別（病院研究室、私設研究室）、セグメント予測■ 英文：Therapeutic Drug Monitoring Market Analysis By Product (Consumables, Equipment, Data Management Services), By Technology (Immunoassays, Proteomic Technologies) By Drug Class (Anti-epileptic s, Antibiotics, Immunosuppressants, Anti-arrhythmics) By End-use (Hospital Labs, Private Labs), and Segment Forecasts To 2024
■ 発行日：2016年8月18日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707842
■ 調査対象地域：グローバル
- 海軍戦闘システムの世界市場2017-2021About naval combat systemsA naval combat system is an integrated system for naval vessels that are fitted with command and control, communication, surveillance, and firearm-launching equipment. Technavio’s analysts forecast the global naval combat systems market to grow at a CAGR of 3.48% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth pr …
- Rex Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Rex Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Rex Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 乳房画像撮影の世界市場予測（～2023年）“The breast imaging market is projected to grow at a CAGR of 8.0% during the forecast period”The global breast imaging market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8.0%. Growth in this market is largely driven by factors such as the rising prevalence of breast cancer, growth in the geriatric population (as age contributes to the risk of breast can …
- ペンタエリトリトールの国際貿易動向This report examines international trade and worldwide market trends pertaining to pentaerythritol. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on pentaerythritol export/import operations segmented by country and region. The report covers the 2006-2011 period, with m …
- 世界のポリオキシメチレン市場2015The Global Polyoxymethylene Industry Report 2015 is a professional and in-depth study on the current state of the Polyoxymethylene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polyoxymethylene market analysis is provided for the international markets including development trends, competitive lan …
- 予防ワクチンの世界市場：弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチンAbout Preventable Vaccines Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adole …
- 先端エネルギー貯蔵システムの世界市場分析：技術別（電池、フライホイール、熱、圧搾空気、溶融塩）、セグメント予測 2022Global Advanced Energy Storage Systems Market By Technology (Batteries, Flywheel, Thermal, Compressed Air, Molten Salt) Is Expected To Reach USD 6.93 Billion By 2022May 2015 Global advanced energy storage systems market is expected to reach USD 6.93 billion by 2022. Increasing demand for utility scale power generation particularly during peak hours is expected to augment demand for advanced energy …
- 脊髄刺激装置の世界市場2016-2020About Neurostimulation Neurostimulation devices are gaining acceptance as an alternative therapy for certain chronic pain conditions. These devices have also been used in the management of neurological disorders like Parkinson’s disease and epilepsy. The currently available neurostimulators mainly focus on SCS, deep brain stimulation (DBS), vagus nerve stimulation (VNS), and sacral nerve stimulati …
- 整形外科手術ロボットの世界市場2017-2021ABSTRACTAbout Orthopedic Surgical Robots Orthopedic surgical robots are systems that are used to perform surgeries such as partial or joint replacement, which is also known as arthroplasty. The current report focuses on robots that are used to conduct orthopedic surgeries on the hip and knee. With the developments in the orthopedic market, there has been an emergence of product offerings, which fa …
- ヘルスケア分析/医療分析の世界市場予測（～2021年）The healthcare analytics market is expected to reach USD 24.55 Billion by 2021 from USD 7.39 Billion in 2016, at a CAGR of 27.1% from 2016 to 2021. The market is mainly driven by factors such as increasing government initiatives to enhance EHR adoption, rising pressure to curb healthcare spending and need for improved patient outcomes, availability of big data in healthcare, rise in venture capita …
- 炭酸水素ナトリウム（重曹）の世界市場2015Sodium bicarbonate market shows stable growth due to its widespread use in the feed and food industries, which together account for more than half of global product consumption. Solvay is the largest sodium bicarbonate producer in the world. Other large producers include Inner Mongolia and Church & Dwight. The majority of sodium bicarbonate today is still produced from soda ash (natural and synthe …
- 耐熱性高分子の世界市場予測（～2021年）：フルオロポリマ、ポリイミド、硫化ポリフェニレン、PBI、PEEK“The global heat resistant polymers market is projected to grow at a CAGR of 6.7% from 2016 to 2021 in terms of value”The global heat resistant polymers market is projected to reach USD 16.67 billion by 2021, at a CAGR of 6.7% from 2016 to 2021. Increasing demand for heat resistant polymers from the transportation end-use industry, especially in the Asia-Pacific region, is anticipated to drive the …
- 世界の一体型セラミックス市場2015The Global Monolithic Ceramics Industry Report 2015 is a professional and in-depth study on the current state of the Monolithic Ceramics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Monolithic Ceramics market analysis is provided for the international markets including development trends, compe …
- 麻痺（Paralysis）：グローバル臨床試験レビュー（2014年上半期）Paralysis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H1, 2014" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- MVAS（モバイル付加価値サービス）市場、アプリケーション及び機会Mobile Value-added Service (VAS) applications represent a key aspect to the ongoing success of mobile network operators and everyone in the mobile communications value chain. With core services, such as bear voice and data communications becoming commodity offerings, wireless service providers are dependent on VAS applications to drive additional revenue and improved margins. This research represe …
